Prometrium Adolescent (12 to 17) Caregiver Administration Guidance

What Is Prometrium and Why Might an Adolescent Need It?

Prometrium is the brand name for oral micronized progesterone, a bioidentical form of the progesterone the body naturally produces. The FDA approved Prometrium capsules for use in adults, and prescribing clinicians may use it off-label or within accepted clinical guidelines for adolescents who need supplemental or replacement progesterone. [1]

Conditions Treated in Adolescents

Three clinical situations account for most Prometrium prescriptions in this age group.

Primary amenorrhea occurs when menstruation has not started by age 15 in a person with breast development, or by age 13 without any secondary sex characteristics. The Endocrine Society's 2023 clinical practice guideline on female puberty notes that progestogen supplementation may be added after adequate estrogen priming to support normal uterine development. [2]

Secondary amenorrhea and anovulatory bleeding are common in adolescents within the first two to three years after menarche because the hypothalamic-pituitary-ovarian axis is still maturing. Cyclic progesterone therapy (typically 10 to 14 days per month) can stabilize the endometrium and produce a predictable withdrawal bleed, reducing the risk of unopposed estrogen effect on the uterine lining. [3]

Gender-affirming hormone therapy in transgender adolescents assigned female at birth may include progesterone to assist in breast tissue development or menstrual suppression, following protocols such as those outlined in the World Professional Association for Transgender Health Standards of Care Version 8. [4]

In each case, the prescribing clinician determines whether Prometrium is appropriate, selects the dose, and sets the duration of treatment. Caregivers should not adjust doses independently.

Understanding the Peanut Oil Allergy Warning

This point deserves its own section before dosing details.

Prometrium capsules are formulated with peanut oil as an excipient. The FDA prescribing information states explicitly that Prometrium is contraindicated in patients with known peanut allergy. [1] Anaphylaxis from peanut oil in pharmaceutical products has been documented, and the risk in a sensitized individual is real even if the person has previously tolerated peanuts in food.

What Caregivers Must Do Before the First Dose

Ask the adolescent directly about any history of peanut reactions, even mild ones such as hives or lip tingling. Review prior allergy test results if available. If there is any doubt, contact the prescribing clinician before opening the first blister pack. Do not assume the prescriber was aware of a newly disclosed allergy. A 2021 review in the Annals of Allergy, Asthma and Immunology confirmed that peanut-derived pharmaceutical excipients carry immunogenic potential even at low concentrations in sensitized patients. [5]

If the adolescent has a confirmed peanut allergy, the prescriber can substitute a compounded micronized progesterone preparation made without peanut oil, or consider an alternative progestogen.

Dosing: What the Prescription Label Tells You

Prometrium comes in 100 mg and 200 mg oral capsules. Dose, frequency, and cycle length vary by indication.

Common Dosing Schedules

| Indication | Typical Dose | Typical Duration | |---|---|---| | Cyclic progesterone for anovulatory bleeding | 200 to 400 mg at bedtime | Days 15 to 26 of a 28-day cycle | | Amenorrhea induction (withdrawal bleed) | 200 to 400 mg at bedtime | 10 to 14 consecutive days | | Continuous progesterone (e.g., gender-affirming therapy) | 100 to 200 mg at bedtime | Daily, ongoing per protocol |

These ranges reflect published clinical practice and the FDA label for adults. [1] The adolescent's specific prescription may differ. Follow the written prescription exactly.

Why Bedtime Dosing Matters

Micronized progesterone is metabolized in the gastrointestinal tract and liver into neuroactive steroids, including allopregnanolone, which has sedative properties through GABA-A receptor modulation. [6] Giving the capsule at bedtime means peak sedation coincides with sleep rather than school or activity. A pharmacokinetic study published in the Journal of Clinical Endocrinology and Metabolism found that peak plasma progesterone concentration after a 200 mg oral dose occurred at approximately 3 hours post-ingestion, with sedation most pronounced in that window. [7]

Give the capsule with a small snack or meal, not on an empty stomach. Food increases bioavailability by approximately 50% and reduces the likelihood of nausea. [1]

Step-by-Step Administration Instructions for Caregivers

Consistent technique reduces missed doses and side effects.

Before Each Dose

1. Check the prescription label and confirm you have the correct capsule strength (100 mg vs. 200 mg).
2. Wash hands with soap and water for at least 20 seconds.
3. Prepare a small food item: a few crackers, a spoonful of peanut butter (if no peanut allergy), or a small glass of milk.
4. Have a full glass of water ready.

Giving the Dose

Hand the adolescent the capsule and the glass of water. The capsule should be swallowed whole. Do not crush, chew, or open the capsule. The contents are an oily suspension; splitting the capsule delivers an unpredictable fraction of the dose and bypasses the timed dissolution intended by the manufacturer.

If the adolescent has difficulty swallowing capsules, notify the prescriber. Compounded sublingual or vaginal forms of micronized progesterone can be considered, though bioavailability profiles differ from oral Prometrium. [8]

After the Dose

Note the time in a medication log or phone calendar. For cyclic protocols (e.g., days 15 to 26), a simple paper calendar with check boxes is effective. Documenting the dose time helps identify patterns if side effects cluster at a specific time of night.

Managing Common Side Effects

Most side effects of Prometrium in adolescents are mild and dose-dependent.

Drowsiness and Dizziness

These are the most frequently reported effects, occurring in roughly 30% of adult patients in clinical trial data from the original Prometrium NDA. [1] The sedative effect is generally considered a benefit when the capsule is given at bedtime. If the adolescent reports next-morning grogginess that interferes with school performance, note the timing and discuss dose adjustment with the prescriber. Do not reduce the dose independently.

Dizziness on standing (orthostatic hypotension) can occur, especially in the first week of a new cycle. Encourage the adolescent to sit on the edge of the bed for 30 seconds before standing after waking.

Breast Tenderness and Bloating

Progesterone-related breast tenderness is common, particularly in the luteal phase equivalent of a cyclic regimen. A well-fitting, supportive bra and reducing caffeine intake may help. Bloating typically resolves within two to three days of completing a cyclic course.

Mood Changes

Some adolescents report mild irritability or low mood during the progesterone phase of a cyclic regimen. A 2017 randomized crossover trial in Psychoneuroendocrinology (N=40 healthy women) found that oral micronized progesterone produced significantly less negative mood effect than medroxyprogesterone acetate over a 12-day observation period. [9] Still, caregivers should track mood alongside physical symptoms in the medication log.

Irregular Spotting

Light spotting during a cyclic course is not unusual and does not indicate treatment failure. Spotting that is heavier than a normal period, lasts more than 7 days, or occurs outside the expected withdrawal window should be reported to the prescriber.

Serious Adverse Effects: Recognize and Act Immediately

The following symptoms require emergency evaluation. Call 911 or go to the nearest emergency department.

Thromboembolic Events

The FDA label for Prometrium carries a warning regarding thromboembolic disorders. [1] Signs include sudden unilateral leg pain or swelling, shortness of breath, sharp chest pain, or coughing up blood. These may indicate deep vein thrombosis or pulmonary embolism. A 2019 Cochrane review of progestogen-only contraceptives found that oral progestogens carry a lower venous thromboembolism risk than combined estrogen-progestogen preparations, but the absolute risk is not zero. [10]

Severe Neurological Symptoms

Sudden severe headache unlike any previous headache, loss of vision in one or both eyes, double vision, or sudden weakness or numbness on one side of the body may indicate a cerebrovascular event. The prescribing information lists these as reasons to discontinue progesterone therapy immediately and seek emergency care. [1]

Signs of Allergic Reaction

Hives, facial swelling, difficulty breathing, or throat tightness within 30 minutes of the first dose should be treated as anaphylaxis. Use an epinephrine auto-injector if available and call 911. This is most likely in the context of undisclosed peanut allergy.

Drug Interactions Caregivers Should Know

Prometrium is metabolized primarily by CYP3A4. Drugs that strongly inhibit CYP3A4 (ketoconazole, clarithromycin, ritonavir) can raise progesterone plasma levels significantly, increasing sedation risk. Drugs that induce CYP3A4 (rifampin, carbamazepine, St. John's Wort) can reduce efficacy. [1]

The interaction with carbamazepine is worth specific attention in adolescents, because carbamazepine is prescribed for seizure disorders and mood stabilization in this age group. If the adolescent takes any anticonvulsant, mood stabilizer, antifungal, or antibiotic, share the complete medication list with the prescriber before the first Prometrium dose.

Alcohol amplifies the sedative effect of micronized progesterone. Caregivers should discuss age-appropriate substance use counseling with the prescriber if relevant.

Storage and Handling

Store Prometrium capsules at controlled room temperature, 59 to 86°F (15 to 30°C). Keep the bottle tightly closed, away from direct light, humidity, and heat. Do not store in a bathroom medicine cabinet where steam from showers raises both temperature and moisture.

Check the expiration date printed on the blister pack or bottle before each new cycle. Expired capsules should be disposed of through an FDA-approved drug take-back program. [11] Do not flush down the toilet unless the FDA flush list specifically includes this medication, which Prometrium is not listed on as of this writing.

If a capsule appears discolored, has a cracked shell, or the oily interior has leaked, discard it and use a replacement from the same prescription.

What to Do If a Dose Is Missed

The approach depends on the dosing schedule.

Cyclic protocol (e.g., days 15 to 26): If the adolescent remembers within the same calendar day, give the dose at bedtime that night with food. If the next day has already started (morning or later), skip the missed dose and continue from the next scheduled day. Do not double-dose to compensate. For a cyclic course, missing one day at the start or end of a 10-to-14-day sequence is unlikely to prevent the expected withdrawal bleed, but the prescriber should be informed.

Daily continuous protocol: Give the missed dose at bedtime the same day it is remembered. If more than 36 hours have passed since the missed dose, skip it and resume the regular schedule. Contact the prescriber if two or more consecutive doses are missed; this may require a clinical reassessment, particularly if the indication is menstrual suppression.

Monitoring and Follow-Up

The prescribing clinician will typically schedule a follow-up visit 4 to 12 weeks after starting Prometrium to assess response and tolerability.

Caregivers can support that visit by bringing a medication log that tracks four items for each cycle: (1) the dates progesterone was given, (2) any side effects and their severity on a 1-to-3 scale, (3) the onset and duration of any bleeding or spotting, and (4) mood or behavioral changes noted by the adolescent or caregiver. This four-item framework gives the prescribing clinician a structured dataset to determine whether the dose, timing, or formulation needs adjustment, rather than relying on recall alone.

Laboratory Monitoring

Routine serum progesterone levels are not required for most adolescent indications, because oral micronized progesterone produces a wide individual variation in peak and trough levels that does not reliably predict clinical response. [7] The prescriber may order a progesterone level in specific circumstances, such as confirming ovulation suppression. In gender-affirming care protocols, hormone panels including estradiol, LH, and FSH are typically drawn every 3 to 6 months per the Endocrine Society guidelines. [12]

Bone Health Considerations

Adolescence is the critical window for peak bone mass accrual. Conditions requiring progesterone therapy (particularly hypothalamic amenorrhea) are associated with low bone mineral density. A 2014 study in the Journal of Bone and Mineral Research found that adolescents with functional hypothalamic amenorrhea had significantly lower lumbar spine Z-scores than age-matched controls. [13] If the underlying condition involves estrogen deficiency, the prescriber may consider dual-energy X-ray absorptiometry (DXA) scanning to establish a baseline, typically after 6 to 12 months of amenorrhea.

Talking With the Adolescent About Treatment

Adolescents between 12 and 17 are in a developmental stage where autonomy over health decisions is increasing. Informed assent, distinct from the parent or guardian's legal consent, is recommended by the American Academy of Pediatrics for medical procedures and ongoing treatments in this age group.

Explain to the adolescent, in language appropriate to their maturity, why the medication is prescribed, what to expect (especially the bedtime drowsiness), and what symptoms they should tell an adult about immediately. An adolescent who understands the purpose of the medication is more likely to take it consistently and report concerns early.

Stigma around hormonal therapy varies by family and community context. Normalizing the conversation by framing Prometrium as a medication that replaces or supplements what the body needs, rather than as a "hormone pill," may reduce reluctance. The prescribing clinician can provide patient-facing educational materials through the practice's patient portal.

Special Populations Within the 12 to 17 Age Group

Adolescents With Hypothyroidism

Thyroid hormone levels affect progesterone metabolism. Hypothyroidism may prolong the half-life of progesterone and increase sedation risk. If the adolescent is on levothyroxine, confirm with the prescriber that thyroid levels are optimized before starting Prometrium.

Adolescents With Epilepsy

Progesterone and its neuroactive metabolites have anticonvulsant properties. Catamenial epilepsy, in which seizure frequency tracks the menstrual cycle, may actually improve with cyclic progesterone therapy; a phase III trial (the NIH Progesterone Trial, NCT00055029) evaluated this in adult women. [14] Conversely, abrupt withdrawal of progesterone at the end of a cyclic course can trigger rebound seizures in susceptible individuals. Caregivers of adolescents with epilepsy should discuss this risk explicitly with both the neurologist and the prescribing endocrinologist.

Adolescents With Depression or Anxiety History

Allopregnanolone, the major CNS-active metabolite of progesterone, has a complex relationship with mood. At physiologic concentrations it is anxiolytic; at rapidly shifting concentrations it may destabilize mood in individuals with a history of premenstrual dysphoric disorder or major depression. The prescriber should be aware of any prior psychiatric diagnosis before initiating Prometrium.